Note 7 - Warrants |
3 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||
| Warrants Disclosure [Text Block] |
7. Warrants
The activity related to warrants during the three months ended March 31, 2026, is summarized as follows:
April 2025 Pre-Funded Warrants
In March 2026, the Company issued pre-funded warrants at a price of $0.585 per warrant to purchase up to an aggregate of 6,399,316 shares of common stock at an exercise price of $0.001 per share, in connection with the third closing of the April 2025 Private Placement (see Note 6, “Stockholders’ Equity” for additional information).
At March 31, 2026, 25,452,768 of the 45,718,344 warrants outstanding and exercisable were pre-funded warrants. |
||||||||||||||||||||||||||||||||||||